Enanta Pharmaceuticals Cuts 37 Jobs in Fiscal Year-End Restructuring
NewsData.io · United States · Sep 29, 2026
Enanta Pharmaceuticals, a Watertown, Massachusetts-based antiviral and immunology biotech, has laid off 37 employees as part of a company-wide rightsizing effort at its fiscal year end. The cuts represent roughly 30% of its 120-person workforce reported as of September 2025. The company cited a need to operate more efficiently while pursuing key clinical readouts for its RSV antiviral zelicapavir and immunology candidate EDP-978. Recruiters with biotech and pharmaceutical placements may find displaced candidates with antiviral and immunology expertise entering the market.
Related stories
Netflix laid off approximately 1,000 employees, including several TV development executives: Lisa Lang McMullen (director of overall deals and…
Airtable is laying off a large but undisclosed portion of its roughly 800 pre-acquisition employees weeks after Milan-based Bending Spoons closed its…
Andreessen Horowitz has laid off the majority of its 34-person team dedicated to helping portfolio companies recruit talent, signaling a shift in how…
Netflix confirmed it is laying off approximately 1,000 employees, representing about 6% of its roughly 16,000-person workforce…